Skip to main content

PROFUND ADVISORS LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1129919 BETHESDA, MD

Position in ALNY

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$4,846,252
-$1,352,713 QoQ
Shares Held
14,647
-6.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,791,137 across 158 Biotechnology names. ALNY ranks #3 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ALNY
Alnylam Pharmaceuticals, Inc.
This page
14,647 $4,846,252

All Filings in ALNY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,846,252 14,647
2025-12-31 $6,198,965 15,589
2025-09-30 $1,612,416 3,536
2025-06-30 $2,092,845 6,418
2025-03-31 $2,383,196 8,826
2024-12-31 $2,281,330 9,695
2024-09-30 $3,320,712 12,074
2024-06-30 $3,499,686 14,402
2024-03-31 $1,385,401 9,270
2023-12-31 $1,594,828 8,332
2023-09-30 $1,285,214 7,257
2023-06-30 $1,468,046 7,729
2023-03-31 $1,356,166 6,770
2022-12-31 $3,261,508 13,724
2022-09-30 $2,619,694 13,088
2022-06-30 $2,013,459 13,805
2022-03-31 $2,445,267 14,975
2021-12-31 $2,788,912 16,446
2021-09-30 $3,638,746 19,272
2021-06-30 $3,400,740 20,061
2021-03-31 $2,910,349 20,613
2020-12-31 $3,076,779 23,673
2020-09-30 $3,138,553 21,556
2020-06-30 $3,711,192 25,057
2020-03-31 $2,279,972 20,946